Saturday, July 30, 2016

FTM (Forget The Market) Reopens Three Shares Options for a Limited Time. Aimed at Cautious Investors Looking for Consistent Performance & Profits

The investment fund took nine years of research and seven years of investor feedback to perfect, with essential lessons learned from each and every successful investment made.

Port Vila, Vanuatu, 28th July 2016 - Investment firm FTM today announced the reopening of three separate share options, projected to provide good yields suitable for those investors looking for consistent performance and profits. This is good news for cautious investors.

FTM has proven the value of solid experience and practical knowledge with more than 76 positive months of returns and NO negative months since inception, in March 2010.

History has shown that experience, in tandem with putting clients' needs first and ensuring capital preservation, counts for a great deal in financial circles. And the FTM management team have more than 60 years of financial industry experience between them.

FTM has demonstrated great resilience via more than 76 consecutive “NO LOSS” months, with a compound annualized rate of 8.74%. This consistently successful investment strategy dates back to 1997 and has been tried and tested throughout some of the worst market conditions, since the great depression.

FTM capital is secured at a rate of three (3) dollars of medical receivables for every one (1) dollar invested. These receivables are currently spread amongst 100 different insurance companies with a maximum of 10% tied to any one company. This “wise spread" strategy ensures the very safest environment for FTM clients.

At the recent FTM Share Issue Launch Event in London, Founder and Managing Director, Endre Dobozy, reminded his guests, “There is no such thing as easy fast money, given that Wall Street has lost over 45% of investors’ money, twice, over the past 13 years and that the average equity mutual fund investor has earned only 2.1% annually for the past 20 years." He concluded, “As of first half of 2016, Hedge Funds are up, on average, just 1.34%. Meanwhile FTM is up 3.73%, 4.93% and 7.98% in their respective share classes - and that is the proof of the pudding!”

The relaunched share options are the brainchild of FTM, a multiple Winner of the Best Fixed income fund offshore, with awards spanning from 2011–2016, and no less than eight prestigious wins to date (listed here  That record of success speaks for itself.

Access to the FTM fund will be limited on a first-come basis up to US 3.5 million. Then it will be capped for around 2 years. Investors interested in knowing more should contact FTM via their website:

About FTM

FTM is a dynamic investment product that places emphasis on capital preservation first and foremost, achieving consistent returns and maintaining low volatility. FTM succeeds by spreading investment risk between FX, Term Deposits and Capital Secured Investments. FTM’s performance is the result of their development of a more stable investment portfolio that provides ROI irrespective of market conditions. The predominant investment strategy used by FTM was born out of an opportunity created by inefficiencies of the US medical system.  Payment delays incurred by doctors, hospitals and medical practitioners in the treatment of personal injury cases had become overwhelmingly onerous. Since good cash flow is crucial to efficient operating costs, doctors, hospitals and medical practitioners are willing to accept less now, rather than waiting years for payment. This enables FTM to fund the purchase of discounted medical receivables and, by assuming the risk, generate a substantial return for clients.

Research and direct purchase of the receivables is done via Medical Accounts Receivables companies which act as a “money bridge” between insurance companies and medical patients. FTM behaves like a bank and loans money out for payment of medical procedures. It is heartening to know that while creating ROI for clients, many sick people are also being helped in the process.

FTM makes sense for all concerned.

For more information:

Contact: Scobie Ryder: Kitaisshiki 6-20- 15 Gifu Japan 500-8227
Tel: +81 907 0314360

Wednesday, July 13, 2016

Steve Gormley Talks About Seventh Point's Private Equity Fund and Investing in Legal Marijuana Dispensary Assets in Los Angeles

Steve Gormley Talks About Seventh Point's Private Equity Fund and Investing in Legal Marijuana Dispensary Assets in Los Angeles

Point Roberts, WA, Delta BC – July 13, 2016 –, a global news source and investor resource covering actively traded sectors including cannabis/hemp and medical marijuana stocks interviews CEO and Founding/Managing Partner of Seventh Point, LLC, a private equity firm investing in assets in the sector.

Seventh Point, LLC is a private equity firm that assembles, owns and operates private equity funds. Seventh Point's private equity funds invest in the acquisition and build-out of legal marijuana dispensary assets and cultivation facilities, industry related technologies and industry related lending platforms.

Seventh Point, LLC combines Fortune 50 financial industry best practices with best of breed cannabis industry expertise.

When asked what his motivation was for entering the sector he explains quite honestly, “I was motivated by money and I am impassioned by the mission that comes along with advocating comprehensive decriminalization.”

Steve tells Investor Ideas that their current focus for legal dispensary assets is in Los Angeles. Steve compares Los Angeles to the legal dispensary industry as to what Silicon Valley is to tech.  “Our investment units contain a dispensary asset that includes the license and the business as a going concern. Right now we are in the process of closing on our first investment unit. We have a signed purchase agreement for a profitable compliant legal medical marijuana dispensary and its related assets. We plan on acquiring ten of these and capturing ten percent of the market in Los Angeles. We are also looking at other opportunities throughout California.”

He said they plan on retaining management but running the company at the highest level and using their Wall Street know-how to grow the business. 

Steve noted that the private equity fund’s mandate is to deploy $75 Million over the next 36-42 months and said they have more than enough capital under management to execute. 

When asked what kind of investors are attracted to the space, he said institutional investors are still on the sideline and that entrepreneurial investors, private investors, family funds are getting educated to make deployments in the sector.

On a personal note he said. “We consider the Government’s law on marijuana is racist.  We think a disproportionate number of young men of color are being prosecuted for non-trafficking related offenses at an alarming rate and created havoc for American taxpayers, as well as the communities at large. While our corporate identity is predicated on activism and advocacy, make no mistake, we are a traditional private equity firm and we are driven by the clear and inevitable business opportunity in marijuana.”

Steve Gormley Bio:

Steve is a renowned expert in the legal marijuana sector and whose analysis is featured prominently in outlets like Forbes, Wall Street Journal, CBS News, US News and World Report, Chicago Tribune and Marketwatch. Steve is a partner in a retail hydroponic supply distributor outfitting commercial-grade cultivators in the Los Angeles area.

Steve Gormley has nearly twenty years’ experience developing, branding, marketing, launching, managing and operating businesses in the US and international markets. He has lived and worked in Asia, Europe, South America and Australia. Steve got his start in media in television production in the early 90’s. After developing content and producing for MTV, Paramount Pictures, Tribune and others, Steve leveraged his expertise in content into the online sector for a new media private equity fund in the late 90’s and early part of the new century. Steve helped develop, launch, manage and sell a number of new media properties and eventually founded a branded entertainment company in China. Steve has also served as managing director for a California based media private equity fund. He deployed C-Level Management Services specializing in start-ups and turn-arounds.

Follow the Sector with the cannabis/hemp and medical marijuana stock directory:

About - News that Inspires Big Ideas
Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also expanded our global coverage to include Latin American stocks, the Middle East, sports and entertainment.

Follow on Twitter!/Investorideas
Follow on Facebook

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:  Global investors must adhere to regulations of each country.